Prenatal diagnosis of placenta accreta spectrum and its management
A case report
DOI:
https://doi.org/10.29193/RMU.40.2.5Keywords:
PLACENTA ACCRETA, PLACENTA INCRETA, PLACENTA PERCRETA, PLACENTARY ACRETISMAbstract
Placenta Accreta Spectrum is a condition associated with high morbidity and mortality. In recent years, there has been an increase in its incidence, highlighting its importance due to the rising rate of cesarean sections which is its main risk factor.
A case is described of a 32-year-old patient with placenta accreta, diagnosed via ultrasound at 31 weeks of gestation. The surgery was meticulously planned with the team, including the placement of balloons in the hypogastric arteries and a double-J catheter, allowing for detailed intraoperative staging.
In relation to the clinical case, a review and update of the pathology is carried out, emphasizing the detailed planning of the surgery and the approach in specialized teams.
References
Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline No. 27a. BJOG 2019; 126(1):e1-e48.
Moradi B, Azadbakht J, Sarmadi S, Gity M, Shirali E, Azadbakht M. El espectro de placenta acreta en la etapa temprana y final del embarazo. Un repaso a través de la imagen. Radiología 2023; 65(6):531-45. doi: 10.1016/j.rx.2023.02.005.
Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, et al. Prophylactic ureteral stent placement and urinary injury during hysterectomy for placenta accreta spectrum. Obstet Gynecol 2022; 140(5):806-11. doi: 10.1097/AOG.0000000000004957.
Matsuo K, Matsuzaki S, Vestal NL, Sangara RN, Mandelbaum RS, Matsushima K, et al. Utilizations and outcomes of intra-arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum. Acta Obstet Gynecol Scand 2021; 100(12):2234-43. doi: 10.1111/aogs.14266.
Hobson SR, Kingdom JC, Murji A, Windrim RC, Carvalho JC, Singh SS, et al. Diagnosis, and management of placenta accreta spectrum disorders. J Obstet Gynaecol Can 2019; 41(7):1035-49. doi: 10.1016/j.jogc.2018.12.004.
Seoud MA, Nasr R, Berjawi GA, Zaatari GS, Seoud TM, Shatila AS, et al. Placenta accreta: elective versus emergent delivery as a major predictor of blood loss. J Neonatal Perinatal Med 2017; 10(1):9-15. doi: 10.3233/NPM-1622.
Stock SJ, Thomson AJ, Papworth S; Royal College of Obstetricians and Gynaecologists. Antenatal corticosteroids to reduce neonatal morbidity and mortality: green-top guideline nº 74. BJOG 2022; 129(8):e35-e60. doi: 10.1111/1471-0528.17027.
Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S; FIGO Placenta accreta diagnosis and management expert consensus panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019; 146(1):20-4. doi: 10.1002/ijgo.12761.
Fox H, Sebire NJ. Pathology of the placenta: an introduction and overview. En: Fox H, Sebire NJ. Pathology of the placenta: major problems in pathology. Philadelphia, PA: Saunders-Elsevier, 2007:1-15.
Escobar-Vidarte MF, Sierra-Ruiz M, Barona-Wiedman JS, Loaiza-Osorio SP, Nieto-Calvache AJ. Oclusión temporal de la aorta abdominal mediante el uso de balón intraarterial en acretismo placentario: reporte de un caso. Rev Chil Obstet Ginecol 2018; 83(3):302-9. doi: 10.4067/s0717-75262018000300302.
Grupo Desarrollador del Consenso, Comité Medicina Materna y Perinatal de la Federación Colombiana de Obstetricia y Ginecología. Consenso colombiano de tratamiento del Espectro de Acretismo Placentario (EAP). Rev Colomb Obstet Ginecol 2022; 73(3):283-316. doi: 10.18597/rcog.3877.